Nitric oxide and mechanisms of redox signalling: Matrix and matrix-metabolizing enzymes as prime nitric oxide targets

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 279-286

  Pfeilschifter, Josef ^a   Eberhardt, Wolfgang ^a   Huwiler, Andrea ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Matrix metabolizing enzyme; Nitric oxide; Redox signalling

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; APOPTOSIS SIGNAL REGULATING KINASE; BASIC FIBROBLAST GROWTH FACTOR; BIGLYCAN; COLLAGEN; CYCLIC AMP; DUAL LEUCINE ZIPPER KINASE; FIBRONECTIN; GELATINASE A; GELATINASE B; GUANYLATE CYCLASE; INTERLEUKIN 1; JANUS KINASE; LAMININ; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MIXED LINEAGE KINASE; NEUROTRANSMITTER; NITRIC OXIDE; OSTEONECTIN; PROTEIN; REACTIVATING KINASE; SPHINGOMYELIN PHOSPHODIESTERASE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ACTIVATED KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CELL ACTIVITY; GENE EXPRESSION; IMMUNITY; MEDIATOR; MODULATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; NITRIC OXIDE; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 0035840841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01326-7     Document Type: Review

References (80)

1. Nitric oxide controls Src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism
2. Oxidative stress and gene regulation
3. Inducible NO synthase: Role in cellular signalling
4. Nitric oxide and the regulation of gene expression
5. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system
6. Implications of the NO/cGMP system for olfaction
7. Rapid and delayed p42/p44 MAPK activation by nitric oxide: The role of cGMP and tyrosine phosphatase inhibition
8. Nitric oxide and superoxide inhibit platelet-derived growth factor receptor phosphotyrosine phosphatases
9. Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase
10. Up-regulation by human recombinant transforming growth factor β-1 of collagen production in cultured dermal fibroblasts is mediated by inhibition of nitric oxide signaling
11. Nitric oxide action on growth factor-elicited signals
12. Biphasic regulation of NFκB activity underlies the pro- and anti-inflammatory actions of nitric oxide
13. Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells
14. A redox-triggered Ras-effector interaction
15. Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide
16. Human rod photoreceptor cGMP-gated channel: Amino acid sequence, gene structure and functional expression
17. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity
18. Nitric oxide and the redox regulation of Janus kinase activity
19. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat renal mesangial cells
20. Amplification of IL-1β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NFκB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways
21. Cytokine-induced expression of tissue plasminogen activator (tPA) is differentially modulated by nitric oxide and ROS in rat renal mesangial cells
22. Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression
23. Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase
24. Progression and regression of glomerulosclerosis
25. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding
26. Nitric Oxide I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
27. Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells
28. Nitric oxide stimulates the stress-activated protein kinase p38 in rat renal mesangial cells
29. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase
30. Selective ceramide binding to protein kinase C-α and -δ isoenzymes in renal mesangial cells
31. Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells
32. Nitric oxide stimulates chronic ceramide formation in glomerular endothelial cells
33. Physiology and pathophysiology of sphingolipid metabolism and signaling
34. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release
35. Biosynthesis and metabolism of endothelium-derived nitric oxide
36. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB
37. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide
38. NO decreases phosphorylation of focal adhesion proteins via reduction of Ca in rat aortic smooth muscle cells
39. Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase
40. The concept of glomerular self-defense
41. A role for superoxide in protein kinase C activation and induction of long-term potentiation
42. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue
43. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds
44. Nitric oxide signaling: A possible role for G proteins
45. Nitric-oxide-stimulated guanine nucleotide exchange on p21ras
46. Differential activation of mitogen-activated protein kinases by nitric-oxide-related species
47. The biology of SPARC, a protein that modulates cell-matrix interactions
48. Complex genetic response of human cells to sublethal levels of pure nitric oxide
49. Nitrosation and oxidation in the regulation of gene expression
50. Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning
51. Nitric oxide: Physiology, pathophysiology and pharmacology
52. Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1β-stimulated rat mesangial cells
53. Ordering the cell death pathway. Differential effects of Bcl-2, an interleukin-1-converting enzyme family protease inhibitor and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells
54. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation
55. Mesangial cells orchestrate inflammation in the renal glomerulus
56. Nitric oxide triggers the expression of pro-inflammatory and protective gene products in mesangial cells and the inflamed glomerulus
57. Nitric oxide stimulates stress-activated protein kinases in glomerular endothelial and mesangial cells
58. Ceramides as key players in cellular stress response
59. Regulation of gene expression by nitric oxide
60. Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the absence and presence of epidermal growth factor
61. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived growth factor-mediated mesangial cell proliferation in vitro
62. Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets
63. Sensing electrons: Protein phosphatase redox regulation
64. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes
65. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action
66. Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity
67. Nitric oxide inhibits c-Jun N-terminal kinase 2 (JNK2) via S-nitrosylation
68. Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor β and fibronectin synthesis induced by thromboxane
69. Inhibition of transforming growth factor β production by nitric oxide-treated chondrocytes: Implications for matrix synthesis
70. Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3
71. Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats
72. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells
73. Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl-channel activation
74. Downregulation of SPARC expression is mediated by nitric oxide in rat renal mesangial cells and during endotoxemia in the rat
75. Interferon-γ regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide
76. A redox site involved in integrin activation
77. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-β1 (TGF-(1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice
78. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras
79. Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium